Structure based design and molecular docking studies for phosphorylated tau inhibitors in Alzheimer's disease

被引：0
|
作者：
Pradeepkiran, J. A. [1 ]
Reddy, P. Hemachandra [1 ]
机构：
[1] Texas Tech Univ, Garrison Inst Aging, Hlth Sci Ctr, 3601 4th St,MS 9424, Lubbock, MS 79430 USA
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2019年 / 72卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [41] ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain
    Herrmann, M
    Golombowski, S
    Kräuchi, K
    Frey, P
    Mourton-Gilles, C
    Hulette, C
    Rosenberg, C
    Müller-Spahn, F
    Hock, C
    EUROPEAN NEUROLOGY, 1999, 42 (04) : 205 - 210
  • [42] New cholinesterase inhibitors for Alzheimer's disease: Structure activity for relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives
    Larik, Fayaz Ali
    Shah, Muhammad Shakil
    Saeed, Aamer
    Shah, Hamid Saeed
    Channar, Pervaiz Ali
    Bolte, Michael
    Iqbal, Jamshed
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 116 : 144 - 150
  • [43] Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
    Pradeepkiran, Jangampalli Adi
    Baig, Javaria
    Islam, Md Ariful
    Kshirsagar, Sudhir
    Reddy, Hemachandra
    AGING AND DISEASE, 2025,
  • [44] Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
    Ishiguro, K
    Ohno, H
    Arai, H
    Yamaguchi, H
    Urakami, K
    Park, JM
    Sato, K
    Kohno, H
    Imahori, K
    NEUROSCIENCE LETTERS, 1999, 270 (02) : 91 - 94
  • [45] QUANTIFICATION OF MULTIPLE PHOSPHORYLATED TAU- EPITOPES FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
    Singer, D.
    Alafuzoff, I.
    Hoffmann, R.
    BIOPOLYMERS, 2009, 92 (04) : 326 - 326
  • [46] Correction to: Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies
    Frederique J. Hart de Ruyter
    Tjado H. J. Morrema
    Jurre den Haan
    Jos W. R. Twisk
    Johannes F. de Boer
    Philip Scheltens
    Baayla D. C. Boon
    Dietmar R. Thal
    Annemieke J. Rozemuller
    Frank D. Verbraak
    Femke H. Bouwman
    Jeroen J. M. Hoozemans
    Acta Neuropathologica, 2023, 145 : 263 - 263
  • [47] Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease
    Zhang, Chunhua
    Tai, Yaojun
    Kong, Min
    Jia, Pengyuan
    Ma, Guozhao
    Ba, Maowen
    JOURNAL OF ALZHEIMERS DISEASE, 2025,
  • [48] Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
    Mattsson-Carlgren, Niklas
    Andersson, Emelie
    Janelidze, Shorena
    Ossenkoppele, Rik
    Insel, Philip
    Strandberg, Olof
    Zetterberg, Henrik
    Rosen, Howard J.
    Rabinovici, Gil
    Chai, Xiyun
    Blennow, Kaj
    Dage, Jeffrey L.
    Stomrud, Erik
    Smith, Ruben
    Palmqvist, Sebastian
    Hansson, Oskar
    SCIENCE ADVANCES, 2020, 6 (16)
  • [49] Discovering Potential Acetylcholinesterase Inhibitors Using Molecular Docking Against Alzheimer's Disease and Angiogenesis
    Chia, Adeline Yoke Yin
    Tan, Amelia Cheng Wei
    Leong, Weng Hhin
    JOURNAL OF VASCULAR RESEARCH, 2019, 56 : 21 - 22
  • [50] γ-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer's Disease
    Trasvina-Arenas, Carlos Humberto
    Medina, Luis Alejandro Ayala
    Vique-Sanchez, Jose Luis
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 12 (02): : 340 - 349
12345